|
1
|
Ludwig S, Klitzsch A and Baniahmad A: The
ING tumor suppressors in cellular senescence and chromatin. Cell
Biosci. 1:252011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doyon Y, Cayrou C, Ullah M, Landry AJ,
Côté V, Selleck W, Lane WS, Tan S, Yang XJ and Côté J: ING tumor
suppressor proteins are critical regulators of chromatin
acetylation required for genome expression and perpetuation. Mol
Cell. 21:51–64. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guérillon C, Bigot N and Pedeux R: The ING
tumor suppressor genes: Status in human tumors. Cancer Lett.
345:1–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ullah M, Pelletier N, Xiao L, Zhao SP,
Wang K, Degerny C, Tahmasebi S, Cayrou C, Doyon Y, Goh SL, et al:
Molecular architecture of quartet MOZ/MORF histone
acetyltransferase complexes. Mol Cell Biol. 28:6828–6843. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagashima M, Shiseki M, Pedeux RM, et al:
A novel PHD-finger motif protein, p47ING3, modulates p53-mediated
transcription, cell cycle control, and apoptosis. Oncogene.
22:343–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y and Li G: ING3 promotes UV-induced
apoptosis via Fas/caspase-8 pathway in melanoma cells. J Biol Chem.
281:11887–11893. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen G, Wang Y, Garate M, Zhou J and Li G:
The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated
ubiquitin-proteasome system. Oncogene. 29:1498–1508. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzuki S, Nozawa Y, Tsukamoto S, Kaneko T,
Imai H and Minami N: ING3 is essential for asymmetric cell division
during mouse oocyte maturation. PLoS One. 8:e747492013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Dai DL, Martinka M and Li G:
Prognostic significance of nuclear ING3 expression in human
cutaneous melanoma. Clin Cancer Res. 13:4111–4116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gunduz M, Ouchida M, Fukushima K, Ito S,
Jitsumori Y, Nakashima T, Nagai N, Nishizaki K and Shimizu K:
Allelic loss and reduced expression of the ING3, a candidate tumor
suppressor gene at 7q31, in human head and neck cancers. Oncogene.
21:4462–4470. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gunduz M, Beder LB, Gunduz E, Nagatsuka H,
Fukushima K, Pehlivan D, Cetin E, Yamanaka N, Nishizaki K, Shimizu
K and Nagai N: Downregulation of ING3 mRNA expression predicts poor
prognosis in head and neck cancer. Cancer Sci. 99:531–538. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Borkosky SS, Gunduz M, Beder L, Tsujigiwa
H, Tamamura R, Gunduz E, Katase N, Rodriguez AP, Sasaki A, Nagai N
and Nagatsuka H: Allelic loss of the ING gene family loci is a
frequent event in ameloblastoma. Oncol Res. 18:509–518. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu M, Chen F, Wang Q, Wang K, Pan Q and
Zhang X: Downregulation of inhibitor of growth 3 is correlated with
tumorigenesis and progression of hepatocellular carcinoma. Oncol
Lett. 4:47–52. 2012.PubMed/NCBI
|
|
14
|
Yang HY, Liu HL, Tian LT, Song RP, Song X,
Yin DL, Liang YJ, Qu LD, Jiang HC, Liu JR and Liu LX: Expression
and prognostic value of ING3 in human primary hepatocellular
carcinoma. Exp Biol Med (Maywood). 237:352–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shah S, Smith H, Feng X, Rancourt DE and
Riabowol K: ING function in apoptosis in diverse model systems.
Biochem Cell Biol. 87:117–125. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cengiz B, Gunduz E, Gunduz M, Beder LB,
Tamamura R, Bagci C, Yamanaka N, Shimizu K and Nagatsuka H:
Tumor-specific mutation and downregulation of ING5 detected in oral
squamous cell carcinoma. Int J Cancer. 127:2088–2094. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong W, Russell M, Suzuki K and Riabowol
K: Subcellular targeting of p33ING1b by phosphorylation-dependent
14-3-3 binding regulates p21WAF1 expression. Mol Cell Biol.
26:2947–2954. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu L, Thakur S, Leong-Quong RY, Suzuki K,
Pang A, Bjorge JD, Riabowol K and Fujita DJ: Src regulates the
activity of the ING1 tumor suppressor. PLoS One. 8:e609432013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eapen SA, Netherton SJ, Sarker KP, Deng L,
Chan A, Riabowol K and Bonni S: Identification of a novel function
for the chromatin remodeling protein ING2 in muscle
differentiation. PLoS One. 7:e406842012. View Article : Google Scholar : PubMed/NCBI
|
